Nanopublications LDF server

Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08900_nanopub.RAlE64lToiTMWGEEo0kDkWUHPdsASTcOyQqmUi_BDnSeA#assertion>. }

• drugbank:DB08900 type drugbank_vocabulary:Drug assertion.
• drugbank:DB08900 label "Teduglutide [drugbank:DB08900]" assertion.
• drugbank:DB08900 seeAlso DB08900 assertion.
• drugbank:DB08900 seeAlso teduglutide.html assertion.
• drugbank:DB08900 seeAlso gattex-drug.htm assertion.
• drugbank:DB08900 identifier "drugbank:DB08900" assertion.
• drugbank:DB08900 description "Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue. It is made up of 33 amino acids and is manufactured using a strain of Escherichia coli modified by recombinant DNA technology. Teduglutide differs from GLP-2 by one amino acid (alanine is substituted by glycine). The significance of this substitution is that teduglutide is longer acting than endogenous GLP-2 as it is more resistant to proteolysis from dipeptidyl peptidase-4. FDA approved on December 21, 2012." assertion.
• drugbank:DB08900 title "Teduglutide" assertion.
• drugbank:DB08900 bio2rdf_vocabulary:identifier "DB08900" assertion.
• drugbank:DB08900 bio2rdf_vocabulary:namespace "drugbank" assertion.
• drugbank:DB08900 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08900" assertion.
• drugbank:DB08900 bio2rdf_vocabulary:x-identifiers.org DB08900 assertion.
• drugbank:DB08900 drugbank_vocabulary:drugbank-id "DB08900" assertion.
• drugbank:DB08900 drugbank_vocabulary:x-cas cas:197922-42-2 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-ahfs ahfs:56:92 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-atc atc:A16AX08 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-chebi chebi:72305 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-kegg kegg:C16049 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-kegg kegg:D06053 assertion.
• drugbank:DB08900 drugbank_vocabulary:x-wikipedia wikipedia:Teduglutide assertion.
• drugbank:DB08900 drugbank_vocabulary:x-ndc ndc:68875-0101-2 assertion.